Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

March 18, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Diabetic Kidney Disease
Interventions
DRUG

BMS-813160

DRUG

Placebo matching with BMS-813160

Trial Locations (62)

2000

Local Institution, Frederiksberg

2820

Local Institution, Gentofte Municipality

3400

Local Institution, Hillerød

7500

Local Institution, Holstebro

11355

Nephrology Associates, Flushing

12206

Albany Medical College, Albany

The Endocrine Group Llp, Albany

19107

Thomas Jefferson University, Philadelphia

20037

George Washington University Medical Faculty Associates, Washington D.C.

20110

Manassas Clinical Research Center, Manassas

22015

Burke Internal Medicine And Research, Burke

23249

Mcguire Va Medical Center, Richmond

23321

Virginia Endocrinology Research, Chesapeake

27705

Duke University, Durham

28204

Metrolina Internal Medicine, Charlotte

28607

Medispect Medical Research, Llc, Boone

29653

Piedmont Health Grp, Llc-Twr Pt Res Ctr, Hodges

30076

Endocrine Research Solutions, Inc., Roswell

30303

Emory University School Of Medicine, Atlanta

33012

International Research Associates, Llc, Hialeah

33024

All Medical Research, Llc, Cooper City

33614

Genesis Clinical Research, Inc., Tampa

35294

Uab Hospital, Birmingham

Univ Of Al At Birmingham, Birmingham

37044

Local Institution, Tours

37232

Vanderbilt University Medical Center, Nashville

43210

Ohio State University Medical Center, Columbus

The Ohio State University Wexner Medical Center, Columbus

43701

Physician Research, Inc., Zanesville

44093

Local Institution, Nantes

44130

Paramount Medical Research & Consulting, Llc, Middleburg Heights

60612

John H. Stroger, Jr. Hospital Of Cook County, Chicago

60805

Research By Design, Llc, Evergreen Park

63128

St Louis Center Clinl Res, St Louis

St. Louis Center For Clinical Research, St Louis

68105

Va Nebraska-Western Iowa Health Care System (Nwihcs), Omaha

75877

Local Institution, Paris

78154

Northeast Clinical Research Of San Antonio, Llc, Schertz

78234

San Antonio Military Medical Center, Fort Sam Houston

78539

Doctors Hospital At Renaissance, Edinburg

80054

Local Institution, Amiens

85012

Akdhc Medical Research Services Llc, Phoenix

86021

Local Institution, Poitiers

90022

Academic Medical Research Institute, Los Angeles

90025

Ucla, Los Angeles

91325

Diabetes Medical Center Of California, Northridge

91606

Providence Clinical Research, North Hollywood

94598

Diablo Clinical Research, Inc., Walnut Creek

03063

Southern Nh Diab And Endo, Nashua

08611

Premier Research, Inc., Trenton

37232-1371

Vanderbilt University Medical Center, Nashville

78234-6200

San Antonio Military Medical Center, Fort Sam Houston

R3A 1R9

Health Sciences Centre Diabetes Research Centre, Winnipeg

A1B 3V6

Eastern Health Sciences Center, St. John's

L6T 0G1

Aggarwal And Associates, Brampton

N2H 5Z8

Clinical Research Solutions, Inc, Kitchener

L4J 8L7

Lmc Diabetes & Endocrinology (Thornhill), Thornhill

M4G 3E8

Lmc Diabetes & Endocrinology (Bayview), Toronto

H7T 2P5

Centre De Recherche Clinique De Laval, Laval

H2R 1V6

Recherche Gcp Research, Montreal

H3T 1E2

Local Institution, Montreal

F38043

Local Institution, Grenoble

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01752985 - Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease | Biotech Hunter | Biotech Hunter